deltatrials
Completed PHASE1 NCT00000393

A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).

Sponsor: National Institute of Mental Health (NIMH)

Conditions Cognition Disorders HIV Infections
Interventions Peptide T
Updated 5 times since 2017 Last updated: Feb 26, 2015 Started: Jan 31, 1988 Primary completion: Jan 31, 1990

This PHASE1 trial investigates Cognition Disorders and HIV Infections and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 5 recorded versions since 1988 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Jan 1988

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
Data source: National Institute of Mental Health (NIMH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Los Angeles, United States